Live Breaking News & Updates on Algernon pharmaceuticals

Stay informed with the latest breaking news from Algernon pharmaceuticals on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Algernon pharmaceuticals and stay connected to the pulse of your community

Algernon NeuroScience and the Centre for Human Drug

VANCOUVER, British Columbia, April 24, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT:...

Canada , Haarlem , Noord-holland , Netherlands , United-kingdom , Vancouver , British-columbia , British , Canadian , Christopherj-moreau , Rick-strassman , Algernon-pharmaceuticals-inc

Drug Repurposing Market Projected to Reach USD 51.8 Billion by 2033, Driven by 4.5% CAGR | Market.us

According to a recent report by Market.us, the Global Drug Repurposing Market size is expected to be worth around USD 51.8 Billion by 2033 from USD 32.1 Billion in 2023, growing at a CAGR of 4.5% during the forecast period from 2024 to 2033.Drug repurposing, also known as drug repositioning or reprofiling, represent...

New-york , United-states , America , Algernon-pharmaceuticals , Celentyx-ltd , Regional-development-status , Immediate-delivery-available-buy-this-premium-research , Chembio-discovery-inc , Paradigm-biopharmaceuticals-ltd , Segue-therapeutics , Sosei-group-corporation

Algernon Pharmaceuticals CEO Christopher J. Moreau to Be Featured on Radius Research's Pitch, Deep Dive and Q&A Webinar on April 16th, 2024 - Algernon Pharmaceuticals (OTC:AGNPF)

VANCOUVER, British Columbia, April 11, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the "Company" or "Algernon") (CSE:AGN) (FRANKFURT: AGW0) (OTCQB:AGNPF), is pleased to invite investors and other interested

United-kingdom , Canada , Vancouver , British-columbia , Canadian , British , Martin-gagel , Christopherj-moreau , Algernon-pharmaceuticals , Company-or-algernon , Neither-the-canadian-securities-exchange , Radius-research-pitch

Algernon Pharmaceuticals Unveils Future Plans

Algernon Pharmaceuticals (TSE:AGN) has released an update. Algernon Pharmaceuticals invites stakeholders to a special CEO interview and Q&A session...

Algernon-pharmaceuticals ,

Cough in Idiopathic Pulmonary Fibrosis Therapeutics Market to Exhibit Immense Growth at a CAGR of 4.9% by 2034

/PRNewswire/ -- DelveInsight's Cough in Idiopathic Pulmonary Fibrosis Market Insights report includes a comprehensive understanding of current treatment...

United-kingdom , United-states , Italy , Germany , France , Guangdong-raynovent , Vicore-pharma , Nitto-denko , Bristol-myers-squibb , Prnewswire-delveinsight , Suplatast-tosilate , Shruti-thakur

DelveInsight Business Research, LLP: Cough in Idiopathic Pulmonary Fibrosis Therapeutics Market to Exhibit Immense Growth at a CAGR of 4.9% by 2034

DelveInsight Business Research, LLP: Cough in Idiopathic Pulmonary Fibrosis Therapeutics Market to Exhibit Immense Growth at a CAGR of 4.9% by 2034
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United-kingdom , United-states , Germany , France , Italy , Vicore-pharma , Dennis-riedl , Guangdong-raynovent , Shruti-thakur , Ark-biosciences , Nitto-denko , Bristol-myers-squibb

Cough in Idiopathic Pulmonary Fibrosis Therapeutics Market to Exhibit Immense Growth at a CAGR of 4.9% by 2034

DelveInsight's Cough in Idiopathic Pulmonary Fibrosis Market Insights report includes a comprehensive understanding of current treatment practices, cough in idiopathic pulmonary fibrosis emerging drugs, market share of individual therapies, and current and forecasted market size from 2020 to 2034, segmented into 7MM [the United States, the EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan].

Germany , France , Italy , United-kingdom , United-states , Vicore-pharma , Guangdong-raynovent , Shruti-thakur , Ark-biosciences , Nitto-denko , Bristol-myers-squibb , Suplatast-tosilate

Algernon Pharmaceuticals Advances DMT Stroke Study

Algernon Pharmaceuticals (TSE:AGN) has released an update. Algernon Pharmaceuticals is set to advance its groundbreaking intravenous DMT stroke res...

Algernon-pharmaceuticals ,

Algernon Pharmaceuticals to Move Forward with Psychedelic Drug DMT Stroke Research Program as its Lead Asset

VANCOUVER, British Columbia, April 01, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that it plans to move forward with its intravenous formulation of its AP-188 (“N,N-Dimethyltryptamine” or “DMT”) stroke research program as its lead asset, after having sold its Ifenprodil research program for USD $2M cash and a 20% common share

Canada , Vancouver , British-columbia , Netherlands , United-kingdom , Canadian , British , Christopherj-moreau , Company-or-algernon , Algernon-pharmaceuticals , Algernon-pharmaceuticals-inc

Algernon Pharmaceuticals Announces Closing of the Acquisition of its Chronic Cough Research Program by U.S. Based Seyltx for USD $2M and a 20% Equity Position

Algernon Pharmaceuticals Announces Closing of the Acquisition of its Chronic Cough Research Program by U.S. Based Seyltx for USD $2M and a 20% Equity Position
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United-states , Canada , Vancouver , British-columbia , United-kingdom , Canadian , British , Dietricha-stephan , Christopherj-moreau , Algernon-ifenprodil , Maxim-group , Canadian-securities-exchange